Feasibility and Safety of Ttransendoscopic Enteral Tubing in Mid-gut
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03335982|
Recruitment Status : Unknown
Verified September 2017 by Faming Zhang, The Second Hospital of Nanjing Medical University.
Recruitment status was: Recruiting
First Posted : November 8, 2017
Last Update Posted : December 2, 2017
|Condition or disease||Intervention/treatment||Phase|
|Transendoscopic Enteral Tubing||Procedure: transendoscopic enteral tubing in mid-gut||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Feasibility and Safety of Ttransendoscopic Enteral Tubing in Mid-gut|
|Actual Study Start Date :||August 1, 2015|
|Estimated Primary Completion Date :||December 1, 2017|
|Estimated Study Completion Date :||December 1, 2017|
transendoscopic enteral tubing in mid-gut
A TET tube was inserted into mid-gut through the nasal orifice and fixed on the pylorus wall by one tiny titanium endoscopic clip under anesthesia. The feasibility, safety, success rate, and satisfaction with TET placement were evaluated for enteral nutrition or fecal microbiota transplantation.
Procedure: transendoscopic enteral tubing in mid-gut
A TET tube was inserted into mid-gut through the nasal orifice and fixed on the pylorus wall by one tiny titanium endoscopic clip under anesthesia.
- success rate [ Time Frame: All patients were followed up from date of intubation to one mouth after discharge ]the success rate of of the TET procedure
- adverse events rate [ Time Frame: All patients were followed up from date of intubation to one mouth after discharge ]Procedure-related and tube-related adverse events after procedure
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03335982
|Contact: Faming Zhang, MD; PhDemail@example.com|
|Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University||Recruiting|
|Nanjing, Jiangsu, China, 210011|
|Contact: Faming Zhang, MD, PhD 086-25-58509883 firstname.lastname@example.org|